Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
Read moreCSE:NF OTCQX:NFUNF Nuclear Fuels Inc. (CSE: NF) (OTCQX: NFUNF) (‘Nuclear Fuels’ or the ‘Company ‘) announces the commencement of its...
Read more(TheNewswire) TORONTO TheNewswire – June 11, 2025 Noble Mineral Exploration Inc. (‘ Noble ‘ or the ‘ Company ‘) (TSXV:...
Read more(TheNewswire) As global demand for rare earth magnets accelerates—driven by electric vehicles, renewable energy systems, and high-performance computing—the need for...
Read moreJuggernaut Exploration (TSXV: UGR,OTCQB:JUGRF,FSE:4JE) is a precious metals exploration company focused on British Columbia’s Golden Triangle — a world-renowned region...
Read moreE-Power Resources Inc. (CSE: EPR) (FSE: 8RO) (‘E-Power’ or the ‘Company’) is pleased to announce the start of the 2025...
Read moreChris Blasi, president of Neptune Global, believes gold still has much more room to run. ‘Some people think gold has...
Read moreAs global automakers brace for fallout from China’s tightening grip on rare earths exports, Hyundai Motor (KRX:005380,OTC Pink:HYMTF) appears to...
Read moreRapid Critical Metals Limited (‘Rapid’ or ‘Company’) is pleased to announce that is increasing its land holding adjacent to the...
Read moreRadiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Download the PDF here. This...
Read moreDisclaimer: newyorkstocksinsider.com, its managers, its employees, andassigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 newyorkstocksinsider.com All Rights Reserved.